Summary
Josh Peters is a biotech founder and CEO with a decade of experience translating academic immunology and -omics expertise into early-stage venture-backed companies. He completed a PhD at MIT in Biological/Biosystems Engineering, where he modeled and engineered immune cell states, and now leads Arpelos Biosciences out of Cambridge, MA. Prior roles across venture and fund teams (82VS, American Cancer Society’s BrightEdge Fund, Area Two Bio Fund) give him uncommon fluency in both science and startup financing. Josh combines deep technical rigor with operator experience in seed-stage company building, often bridging lab-scale discovery and investor-facing strategy. He brings a chemical engineering undergraduate foundation and a track record of co-founding and advising bio-focused ventures, signaling a practical appetite for translating complex biology into investable products.
10 years of coding experience
2 years of employment as a software developer
Doctor of Philosophy - PhD, Biological/Biosystems Engineering, Doctor of Philosophy - PhD, Biological/Biosystems Engineering at Massachusetts Institute of Technology
Bachelor’s Degree, Chemical Engineering, Bachelor’s Degree, Chemical Engineering at University of Pittsburgh